Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 2
2002 7
2003 13
2004 10
2005 26
2006 23
2007 22
2008 19
2009 27
2010 36
2011 32
2012 27
2013 15
2014 24
2015 35
2016 32
2017 26
2018 38
2019 22
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

391 results
Results by year
Filters applied: . Clear all
Page 1
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.
Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Brooks C, Attwood S, Harrison R, Barr H, Moayyedi P; AspECT Trial Team. Jankowski JAZ, et al. Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. Lancet. 2018. PMID: 30057104 Free PMC article. Clinical Trial.
Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.
Lozano I, Sanchez-Insa E, de Leiras SR, Carrillo P, Ruiz-Quevedo V, Pinar E, Gopar-Gopar S, Bayon J, Mañas P, Lasa G, CruzGonzalez I, Hernandez F, Fernandez-Portales J, Fernandez-Fernandez J, Pérez-Serradilla A, de la Torre Hernandez JM, Gomez-Jaume A. Lozano I, et al. Am J Cardiol. 2016 Feb 1;117(3):366-8. doi: 10.1016/j.amjcard.2015.11.007. Epub 2015 Nov 18. Am J Cardiol. 2016. PMID: 26708640 Clinical Trial.
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
Kaitu'u-Lino TJ, Brownfoot FC, Beard S, Cannon P, Hastie R, Nguyen TV, Binder NK, Tong S, Hannan NJ. Kaitu'u-Lino TJ, et al. PLoS One. 2018 Feb 21;13(2):e0188845. doi: 10.1371/journal.pone.0188845. eCollection 2018. PLoS One. 2018. PMID: 29466360 Free PMC article.
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
Çelebi A, Aydın D, Kocaman O, Konduk BT, Şentürk Ö, Hülagü S. Çelebi A, et al. Turk J Gastroenterol. 2016 Sep;27(5):408-414. doi: 10.5152/tjg.2016.15514. Turk J Gastroenterol. 2016. PMID: 27782887 Free article. Clinical Trial.
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
Scheinberg M, Pott Júnior H, Macêdo EA, Bocchi de Oliveira MF, Ecclissato C, Amazonas RB. Scheinberg M, et al. Drug Des Devel Ther. 2018 Sep 6;12:2775-2783. doi: 10.2147/DDDT.S172068. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30233140 Free PMC article. Clinical Trial.
391 results
Jump to page
Feedback